Thomas Wanek

2.5k total citations
92 papers, 1.9k citations indexed

About

Thomas Wanek is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thomas Wanek has authored 92 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 35 papers in Pediatrics, Perinatology and Child Health and 32 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thomas Wanek's work include Drug Transport and Resistance Mechanisms (53 papers), Pharmacological Effects and Toxicity Studies (35 papers) and Radiopharmaceutical Chemistry and Applications (18 papers). Thomas Wanek is often cited by papers focused on Drug Transport and Resistance Mechanisms (53 papers), Pharmacological Effects and Toxicity Studies (35 papers) and Radiopharmaceutical Chemistry and Applications (18 papers). Thomas Wanek collaborates with scholars based in Austria, Germany and Norway. Thomas Wanek's co-authors include Oliver Langer, Claudia Kuntner, Johann Stanek, Severin Mairinger, Markus Müller, Thomas Filip, Wolfgang Löscher, Jens P. Bankstahl, Marion Bankstahl and Michael Sauberer and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas Wanek

86 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Wanek Austria	24	1.0k	572	507	504	254	92	1.9k
Claudia Kuntner Austria	25	837 0.8×	511 0.9×	412 0.8×	718 1.4×	203 0.8×	90	1.9k
Johann Stanek Austria	22	1.0k 1.0×	642 1.1×	284 0.6×	270 0.5×	92 0.4×	62	1.5k
Severin Mairinger Austria	18	658 0.7×	360 0.6×	215 0.4×	229 0.5×	94 0.4×	66	980
Pavitra Kannan United States	18	517 0.5×	233 0.4×	404 0.8×	161 0.3×	65 0.3×	33	1.2k
Akiko Hatori Japan	27	456 0.5×	121 0.2×	754 1.5×	607 1.2×	142 0.6×	106	2.0k
Tomoteru Yamasaki Japan	27	450 0.4×	119 0.2×	809 1.6×	592 1.2×	149 0.6×	117	2.1k
Joji Yui Japan	26	407 0.4×	118 0.2×	609 1.2×	500 1.0×	113 0.4×	82	1.7k
Toshimitsu Fukumura Japan	28	425 0.4×	157 0.3×	620 1.2×	1.2k 2.3×	144 0.6×	137	2.9k
Bertrand Kühnast France	31	576 0.6×	89 0.2×	1.2k 2.4×	1.1k 2.2×	355 1.4×	99	3.1k
Takashi Kuwabara Japan	22	803 0.8×	79 0.1×	883 1.7×	363 0.7×	89 0.4×	56	2.2k

Countries citing papers authored by Thomas Wanek

Since Specialization

Citations

This map shows the geographic impact of Thomas Wanek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wanek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wanek more than expected).

Fields of papers citing papers by Thomas Wanek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Wanek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wanek. The network helps show where Thomas Wanek may publish in the future.

Co-authorship network of co-authors of Thomas Wanek

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wanek. A scholar is included among the top collaborators of Thomas Wanek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wanek. Thomas Wanek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Balber, Theresa, Hemma Schueffl, Marie Brandt, et al.. (2025). Site-Selectively Functionalized Albumin with DFO*Maleimide for ⁸⁹Zr-Radiolabeling Yields a Metabolically Stable PET Probe that Enables Late Time-Point Tumor Imaging in Mice. Journal of Medicinal Chemistry. 68(12). 12925–12939.

Wanek, Thomas, Marco Raabe, Md Noor A Alam, et al.. (2024). Functionalization of 68Ga-Radiolabeled Nanodiamonds with Octreotide Does Not Improve Tumor-Targeting Capabilities. Pharmaceuticals. 17(4). 514–514.

Wanek, Thomas, et al.. (2024). Recent Advances on Pt-Based Compounds for Theranostic Applications. Molecules. 29(15). 3453–3453. 2 indexed citations

Filip, Thomas, Johann Stanek, Marcus Hacker, et al.. (2024). Characterization of a Syngeneic Orthotopic Model of Cholangiocarcinoma by [18F]FDG-PET/MRI. Cancers. 16(14). 2591–2591.

Mairinger, Severin, Thomas Filip, Johann Stanek, et al.. (2023). Influence of P-glycoprotein on pulmonary disposition of the model substrate [11C]metoclopramide assessed by PET imaging in rats. European Journal of Pharmaceutical Sciences. 183. 106404–106404. 5 indexed citations

Friske, Joachim, Thomas Wanek, Lukas Nics, et al.. (2022). CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [68Ga]Ga-Pentixafor in CRC Imaging. Cancers. 14(22). 5549–5549. 5 indexed citations

Stéen, E. Johanna L., Jesper Tranekjær Jørgensen, Christoph Denk, et al.. (2021). Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted In Vivo Chemistry. ACS Pharmacology & Translational Science. 4(2). 824–833. 61 indexed citations

Wanek, Thomas, Michael Sauberer, Thomas Filip, et al.. (2021). Influence of ABC transporters on the excretion of ciprofloxacin assessed with PET imaging in mice. European Journal of Pharmaceutical Sciences. 163. 105854–105854. 10 indexed citations

Mairinger, Severin, Thomas Filip, Michael Sauberer, et al.. (2020). Assessing the Activity of Multidrug Resistance–Associated Protein 1 at the Lung Epithelial Barrier. Journal of Nuclear Medicine. 61(11). 1650–1657. 21 indexed citations

10.

Krohn, Markus, Severin Mairinger, Thomas Wanek, et al.. (2019). Generation and Characterization of an Abcc1 Humanized Mouse Model (hABCC1) with Knockout Capability. Molecular Pharmacology. 96(2). 138–147. 9 indexed citations

11.

Mairinger, Severin, Markus Krohn, Thomas Wanek, et al.. (2018). Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[11C]Methylpurine in Mice. Molecular Imaging and Biology. 21(2). 306–316. 17 indexed citations

12.

Traxl, Alexander, Elisabeth Glitzner, Thomas Wanek, et al.. (2017). Hepatocyte-Specific Deletion of EGFR in Mice Reduces Hepatic Abcg2 Transport Activity Measured by [11C]erlotinib and Positron Emission Tomography. Drug Metabolism and Disposition. 45(10). 1093–1100. 10 indexed citations

13.

Wanek, Thomas, Emina Halilbasic, Michele Visentin, et al.. (2016). Influence of 24-Nor-Ursodeoxycholic Acid on Hepatic Disposition of [18F]Ciprofloxacin, a Positron Emission Tomography Study in Mice. Journal of Pharmaceutical Sciences. 105(1). 106–112. 5 indexed citations

14.

Wanek, Thomas, Christoph Denk, Johann Stanek, et al.. (2016). Synthesis and preclinical characterization of 1-(6′-deoxy-6′-[18F]fluoro-β-d-allofuranosyl)-2-nitroimidazole (β-6′-[18F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxia. Bioorganic & Medicinal Chemistry. 24(21). 5326–5339. 12 indexed citations

15.

Traxl, Alexander, Thomas Wanek, Severin Mairinger, et al.. (2015). Breast Cancer Resistance Protein and P-Glycoprotein Influence In Vivo Disposition of ¹¹C-Erlotinib. Journal of Nuclear Medicine. 56(12). 1930–1936. 49 indexed citations

16.

Römermann, Kerstin, Thomas Wanek, Marion Bankstahl, et al.. (2013). (R)-[11C]verapamil is selectively transported by murine and human P-glycoprotein at the blood–brain barrier, and not by MRP1 and BCRP. Nuclear Medicine and Biology. 40(7). 873–878. 64 indexed citations

17.

Philippe, C., Lukas Nics, Claudia Kuntner, et al.. (2013). Preclinical in vitro & in vivo evaluation of [11C]SNAP-7941 – the first PET tracer for the melanin concentrating hormone receptor 1. Nuclear Medicine and Biology. 40(7). 919–925. 17 indexed citations

18.

Fuereder, Thorsten, Thomas Wanek, Doris Hoeflmayer, et al.. (2011). Gastric Cancer Growth Control by BEZ235 In Vivo Does Not Correlate with PI3K/mTOR Target Inhibition but with [18F]FLT Uptake. Clinical Cancer Research. 17(16). 5322–5332. 31 indexed citations

19.

Kuntner, Claudia, Thomas Wanek, Martin Hoffer, et al.. (2010). Radiosynthesis and Assessment of Ocular Pharmacokinetics of 124I-Labeled Chitosan in Rabbits Using Small-Animal PET. Molecular Imaging and Biology. 13(2). 222–226. 16 indexed citations

20.

Mairinger, Severin, Oliver Langer, Claudia Kuntner, et al.. (2010). Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate. Nuclear Medicine and Biology. 37(5). 637–644. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact